Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government-funding lapse notice and operating status details; updated to version v3.2.0. - Removed reference to v3.1.0.SummaryDifference4%
- Check18 days agoChange Detected- Capitalization correction: Hurler-Scheie syndrome (from Hurler-scheie syndrome). - Version tag update: Revision: v3.1.0 (from v3.0.2).SummaryDifference0.2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedNew version v3.0.2 replaces v3.0.1, indicating a minor update. The 'Back to Top' element was removed, signaling a small UI cleanup.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on specific diseases and a new version revision. Notably, the previous mentions of certain syndromes and conditions have been removed.SummaryDifference6%
- Check53 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%
Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.